Akba stock earnings
AKBA | Stock Snapshot - Fidelity Apr 03, 2020 · The options have an exercise price of $7.58 per share, which is equal to the closing price of Akebia's common stock on the grant date. About Akebia TherapeuticsAkebia Therapeutics (AKBA), Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease. AKBA | Akebia Therapeutics Inc. Analyst Estimates & Rating ... Akebia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. AKBA updated stock price target summary. Akebia Therapeutics (AKBA) Q4 2019 Earnings Snapshot ... Mar 10, 2020 · — AKBA stock dipped more than 5% in the pre-market trading session. We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips. Also Read: Lumentum stock gains momentum as it surpasses Q4 estimates. Most Popular. Akebia Therapeutics Inc. (AKBA) Earnings
Akebia Therapeutics, Inc. (AKBA) Q1 2019 Earnings Call ...
AKBA Stock | AKEBIA THERAPEUTICS Stock Price Today ... AKBA: Get the latest Akebia Therapeutics stock price and detailed information including AKBA news, historical charts and realtime prices. AKBA - Akebia Therapeutics Stock Price - Barchart.com Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -35.56% and -27.09%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock… EarningsWhispers - Investors Sign Up The Earnings Whisper Grade identifies where a stock is in the Earnings Expectation Life Cycle with the A+'s being in the Positive Earnings stage and, on average, gaining 7.33% from two days following the earnings release until the close just before its next earnings release - outperforming the overall stock market by 263%. Stocks with an AKBA | Stock Snapshot - Fidelity
Akebia Therapeutics (AKBA) Q4 2018 Earnings Conference Call Transcript Motley Fool Mar-18-19 04:05PM Akebia Therapeutics Announces Preliminary Full-Year 2018 Financial Results and Business Highlights Business Wire
Akebia Therapeutics, Inc. (AKBA) Interactive Stock Chart ... Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, granted eight newly Akebia Therapeutics Inc Stock Quote: AKBA Stock News ... Nov 06, 2019 · AKBA, Akebia Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines
AKBA | Akebia Therapeutics Inc. Analyst Estimates & Rating ...
Find the latest Earnings Report Date for Akebia Therapeutics, Inc. Common Stock (AKBA) at Nasdaq.com. Akebia Therapeutics, Inc. Common Stock (AKBA) Stock Quotes ... Mar 10, 2020 · Akebia Therapeutics, Inc. Common Stock (AKBA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. (AKBA) Q4 2019 Earnings Call Transcript. Earnings Whisper Number for AKBA: Akebia Therapeutics Aug 08, 2019 · Akebia Therapeutics (AKBA) reports earnings on 6/9/2020. Shares are up 1.3% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock … Akebia Therapeutics Earnings Release Date - AKBA ...
Stock Summary - TD Ameritrade
Mar 27, 2020 · Stock quote for Akebia Therapeutics, Inc. Common Stock Common Stock (AKBA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. AKBA - Akebia Therapeutics Summary, Stock Quote and News ... Jan 01, 2010 · Akebia Therapeutics (NASDAQ: AKBA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on AKBA Earnings Date, Forecast and Report (Akebia Therapeutics)
Find real-time AKBA - Akebia Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. AKBA - Akebia Therapeutics Inc Stock quote - CNNMoney.com Markets AKBA Stock Price, Forecast & News (Akebia Therapeutics) Researching Akebia Therapeutics (NASDAQ:AKBA) stock? View AKBA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.